This protocol is judged by an institutional evaluate board, an independent team that assessments any clinical trials involving humans. If a research requires a Plan I drug, after the board approves the protocol as ethical, the scientists really need to apply for an investigational new drug (IND) number within the FDA.And since the copyright goes th